Article
Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials.
Clinical and experimental rheumatology - 1 Feb 2026
Rivero Gallegos Daphne, Pais Faye M, Lan Ting-Yuan, Papadopoulou Charalampia, Joerns Elena K, Paul Jisna, Rojas Serrano Jorge, Kulkarni Tejaswini, Gandiga Prateek C, So Ho, Houghton Kristin, Bagri Narendra, Jansen Marc, Bader Meunier Brigitte, Wilfong Erin M, Aggarwal Rohit, Hallowell Robert W, Nagaraja Vivek
Abstract excerpt
Interstitial lung disease (ILD) affects a significant proportion of adults and children with idiopathic inflammatory myopathies (IIM-ILD and JIIM-ILD). Despite its major impact on mortality and therapeutic decision‑making, robust studies and clinical trials to inform evidence‑based practice are strikingly scarce. Heterogeneous clinical manifestations, variable testing practices, and lack of widely accepted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.